Review
Open access
Sep 2026
BMAL1 in cardiovascular diseases: Molecular mechanisms, circadian regulation and translational perspectives (Review)
Current evidence does not support viewing BMAL1 as simply protective or harmful, and small-molecule clock modulators, chronotherapy and non-pharmacological interventions, as well as time-resolved multi-omics and machine-learning approaches are assessed.
Yu Liang, Ting-Jin Chen, Xue-Mei Wen et al.
· Molecular Medicine Reports · 0 citations